Page last updated: 2024-08-23

perfosfamide and thiotepa

perfosfamide has been researched along with thiotepa in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	6 (85.71)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bast, RC; Lidor, YJ; Peters, WP; Shpall, EJ	1
Antman, KH; Eder, JP; Frei, E; Herman, TS; Holden, SA; Teicher, BA	1
Cheung, NK; Gulati, SC; Heller, G; Kushner, BH; O'Reilly, RJ	1
Cathcart, KN; Cucchi, CA; Flatow, JL; Frei, E; Holden, SA; Korbut, TT; Teicher, BA	1
Braine, HG; Clarke, B; Davidson, NE; Davis, JM; Huelskamp, AM; Noga, SJ; Ohly, K; Passos-Coelho, JL; Schepers, KG; Wright, SK	1
Davidson, NE; Davis, J; Huelskamp, AM; Kennedy, MJ; Noga, SJ; Ohly, K; Passos-Coelho, J	1
Gurtler, J; Liebmann, J	1

Trials

1 trial(s) available for perfosfamide and thiotepa

Article	Year
Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:3 Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Breast Neoplasms; Cyclophosphamide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Leukocyte Count; Middle Aged; Platelet Count; Predictive Value of Tests; Thiotepa	1995

Article

Year

Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:3

Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Breast Neoplasms; Cyclophosphamide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Leukocyte Count; Middle Aged; Platelet Count; Predictive Value of Tests; Thiotepa

1995

Other Studies

6 other study(ies) available for perfosfamide and thiotepa

Article	Year
Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer. International journal of cancer, 1991, Nov-11, Volume: 49, Issue:5 Topics: Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Cyclophosphamide; Drug Synergism; Female; Humans; Melphalan; Ovarian Neoplasms; Thiotepa; Tumor Cells, Cultured	1991
Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination. Seminars in oncology, 1990, Volume: 17, Issue:1 Suppl 3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Cell Hypoxia; Cell Survival; Cyclophosphamide; Drug Administration Schedule; Drug Combinations; Fluorocarbons; Half-Life; Humans; Hydroxyethyl Starch Derivatives; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Thiotepa; Tumor Cells, Cultured	1990
Autografting with bone marrow exposed to multiple courses of very high dose cyclophosphamide in vivo and to 4-hydroperoxycyclophosphamide in vitro. Medical and pediatric oncology, 1990, Volume: 18, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Marrow; Bone Marrow Transplantation; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoiesis; Humans; Infant; Melphalan; Neuroblastoma; Neutrophils; Thiotepa; Vincristine	1990
Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo. Cancer research, 1988, Jan-01, Volume: 48, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Survival; Cyclophosphamide; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Thiotepa; Tumor Cells, Cultured	1988
Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with m Cancer research, 1993, Nov-15, Volume: 53, Issue:22 Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Length of Stay; Leukocyte Count; Middle Aged; Neutrophils; Novobiocin; Recombinant Proteins; Thiotepa	1993
Combination intraventricular therapy with thiotepa and cytarabine in meningeal carcinomatosis due to breast cancer: in vitro evidence for supra-additive cytotoxicity. Anti-cancer drugs, 1995, Volume: 6, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Drug Resistance; Drug Synergism; Female; Humans; Injections, Intraventricular; Meningeal Neoplasms; Middle Aged; Salvage Therapy; Thiotepa; Tumor Cells, Cultured	1995